Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia

NCT01350999 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

503

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: omega-3-acid ethyl esters 90 (TAK-085)
DRUG: Eicosapentaenoic acid-ethyl (EPA)

Sponsor

Takeda